DividendMapper
Lazard Inc logo

LAZ

Lazard Inc

  • Financial
  • US companies in Financial - Capital Markets (14)
  • NYSE · USD
  • Mkt cap $3.7bn

$38.17

as of 27 Oct 2026, 35% below its 52-week high

Screens as reasonably placed to keep growing its dividend, with low cut-risk signals.

These scores are a resilience check on the dividend, not a recommendation to buy or sell. They are not financial advice.

Trailing yield
5.24%Last 12 months of regular payments at today's price
Forward yield
5.28%Each payment expected in the next 12 months, not the latest one doubled
Cash cover
3.6×Free cash flow over dividends paid
Earnings cover
1.0×Insurers and banks set dividends from capital generation, so their accounting earnings can sit well below the payout.
5y dividend growth
+1.2% a yearLast cut in FY2019
Next ex-dividend date
Declared2 Nov 2026Quarterly dividend of $0.50

Compared with US companies in Financial - Capital Markets (14)

  • Trailing yield is higher than all 12 other US companies in Financial - Capital Markets with a yield figure.
  • 5y dividend growth (as paid) is lower than 10 of the 12 other US companies in Financial - Capital Markets with a 5y growth figure.

Quality

51

Moderate

Capacity to keep growing the dividend

Risk

30

Low

Signals of dividend-cut pressure

Trim

45

Low

How extended the valuation looks

Why Quality is 51

LAZ against US companies in Financial - Capital Markets (14)

Valuation against its own history

As of the last reported period (30 Sept 2026). P80 means the figure is higher than 80% of LAZ’s past readings.

  • P/E19.8×P85, poor for this measure
  • Yield5.52%P60, neutral for this measure
  • DGR 5y+1.2%P50, neutral for this measure

Net debt / EBITDA is left out: for banks and insurers, debt is part of the business, so the ratio says little.

Open valuation history

Forecast your income with the LAZ dividend calculator

Inspect surfaces history; it does not predict the future. Nothing here is financial advice or an instruction to buy or sell. Always do your own research. See the Terms of Service.